NVRO's fourth-quarter earnings surpass the Zacks Consensus Estimate, while worldwide revenues decline year over year. The ...

Nevro's comprehensive HFX™ spinal cord stimulation (SCS) platform includes the Senza® SCS system and support services for the treatment of chronic pain of the trunk and limb and painful ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

Patents covering Senza HFX iQ and other Nevro products are listed at Nevro/patents . To learn more about Nevro, visit and connect with us on LinkedIn , X , Facebook , and Instagram . Forward ...

Nevro has also focused on advancing its product portfolio. The launch of the HFX AdaptivAI platform in the U.S. in November 2024 represents a significant step in this direction. Additionally ...